Aclaris Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.About ACRS
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.
CEONeal S. Walker
CEONeal S. Walker
Employees64
Employees64
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2012
Founded2012
Employees64
Employees64
ACRS Key Statistics
Market cap351.58M
Market cap351.58M
Price-Earnings ratio-2.43
Price-Earnings ratio-2.43
Dividend yield—
Dividend yield—
Average volume1.01M
Average volume1.01M
High today$3.36
High today$3.36
Low today$3.24
Low today$3.24
Open price$3.36
Open price$3.36
Volume327.71K
Volume327.71K
52 Week high$4.89
52 Week high$4.89
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
With a market cap of 351.58M, Aclaris Therapeutics(ACRS) trades at $3.25. The stock has a price-to-earnings ratio of -2.43.
On 2026-02-13, Aclaris Therapeutics(ACRS) stock moved within a range of $3.24 to $3.36. With shares now at $3.25, the stock is trading +0.2% above its intraday low and -3.4% below the session's peak.
Trading volume for Aclaris Therapeutics(ACRS) stock has reached 327.71K, versus its average volume of 1.01M.
Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $4.89 and a low of $1.05.
Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $4.89 and a low of $1.05.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.